Physician profile
Jorge Guttin
NPI 1497730337
$2,614.53
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $437 · 2021: $960 · 2022: $525 · 2023: $17.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $548.09 | 2019-2022 | |
| Amarin Pharma, INC. | $294.55 | 2019-2021 | |
| Novo Nordisk INC | $214.83 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $213.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $197.95 | 2019-2023 | |
| Amgen INC. | $175.67 | 2019-2021 | |
| Esperion Therapeutics, INC. | $149.61 | 2020-2021 | |
| Boston Scientific Corporation | $147.41 | 2022 | |
| Astellas Pharma US INC | $117.09 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $101.30 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $68.14 | 2019-2021 | |
| Endologix LLC | $47.43 | 2021 | |
| Vifor Pharma, INC. | $46.46 | 2021 | |
| Pfizer INC. | $43.00 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $38.83 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $38.05 | 2019-2021 | |
| Abbott Laboratories | $30.75 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.00 | 2021 | |
| Avinger INC. | $20.41 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.13 | 2020 | |
| Medicomp INC | $16.74 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.83 | 2021 | |
| Heartflow, INC. | $15.73 | 2019 | |
| Inari Medical, INC. | $14.64 | 2021 | |
| Medtronic, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Guttin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.